DE60311351D1 - Verwendung von Zeoliten zur Herstellung oraler Zubereitungen zur Behandlung von Vergiftung - Google Patents

Verwendung von Zeoliten zur Herstellung oraler Zubereitungen zur Behandlung von Vergiftung

Info

Publication number
DE60311351D1
DE60311351D1 DE60311351T DE60311351T DE60311351D1 DE 60311351 D1 DE60311351 D1 DE 60311351D1 DE 60311351 T DE60311351 T DE 60311351T DE 60311351 T DE60311351 T DE 60311351T DE 60311351 D1 DE60311351 D1 DE 60311351D1
Authority
DE
Germany
Prior art keywords
zeolites
poisoning
preparation
treatment
oral preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60311351T
Other languages
English (en)
Other versions
DE60311351T2 (de
Inventor
Mauro Fanelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geomedical SRL
Original Assignee
Geomedical SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geomedical SRL filed Critical Geomedical SRL
Publication of DE60311351D1 publication Critical patent/DE60311351D1/de
Application granted granted Critical
Publication of DE60311351T2 publication Critical patent/DE60311351T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
DE60311351T 2002-06-07 2003-05-15 Verwendung von Zeoliten zur Herstellung oraler Zubereitungen zur Behandlung von Vergiftung Expired - Lifetime DE60311351T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI001246A ITMI20021246A1 (it) 2002-06-07 2002-06-07 Composizioni minerali detossinanti a base di zeoliti ad elevata capacita' di scambio cationico
ITMI20021246 2002-06-07

Publications (2)

Publication Number Publication Date
DE60311351D1 true DE60311351D1 (de) 2007-03-15
DE60311351T2 DE60311351T2 (de) 2007-05-24

Family

ID=29434443

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60311351T Expired - Lifetime DE60311351T2 (de) 2002-06-07 2003-05-15 Verwendung von Zeoliten zur Herstellung oraler Zubereitungen zur Behandlung von Vergiftung

Country Status (7)

Country Link
US (1) US20030228377A1 (de)
EP (1) EP1369121B1 (de)
AT (1) ATE352310T1 (de)
DE (1) DE60311351T2 (de)
ES (1) ES2280645T3 (de)
IT (1) ITMI20021246A1 (de)
PT (1) PT1369121E (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050031708A1 (en) * 2003-08-06 2005-02-10 Portney Micah S. Composition comprising a zeolite compound for treatment of diseases
WO2005041657A1 (en) * 2003-10-20 2005-05-12 Framework Therapeutics, L.L.C. Zeolite molecular sieves for the removal of toxins
DE102005053090A1 (de) * 2005-11-04 2007-05-10 Hubert Danz Verwendung eines aktivierten Zeolithen als pharmazeutisches Mittel für die Reduzierung giftiger Stoffe
WO2010057849A1 (de) 2008-11-21 2010-05-27 Froximun Ag Verfahren zur reduktion der konzentration von aminen und deren salzen
US20100173016A1 (en) * 2009-01-08 2010-07-08 Reynolds Paul J Compositions and methods for the absorption, chelation, and elimination of trace metals
IT1396424B1 (it) * 2009-06-05 2012-11-23 Hf Europ Srl Prodotti alimentari comprendenti zeoliti
IT1403586B1 (it) * 2010-12-02 2013-10-31 Hf Europ Srl Nuovo uso di composizioni e di prodotti alimentari comprendenti ossidi e/o idrossidi
JP6071906B2 (ja) 2011-02-11 2017-02-01 ズィーエス・ファーマ，インコーポレーテッド 高カリウム血症の処置のための微孔質ジルコニウムケイ酸塩
US9943637B2 (en) 2012-06-11 2018-04-17 ZS Pharma, Inc. Microporous zirconium silicate and its method of production

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4627972A (en) * 1984-11-16 1986-12-09 Union Carbide Corporation Effervescent dentifrice
HU206484B (en) * 1989-03-24 1992-11-30 Orszagos Frederic Joliot Curie Silicium-containing environment-protecting composition adsorbing radioactive metal-isotopes and toxic heavy metals and process for producing pharmaceutical compositions containing this active component
DE69501041T2 (de) * 1995-08-14 1998-05-20 Geomedical S R L Topische wässrige Gele oder Suspension auf Basis von pulverisiertem Vulkanischen oder diagenischem Minerale

Also Published As

Publication number Publication date
ES2280645T3 (es) 2007-09-16
US20030228377A1 (en) 2003-12-11
ITMI20021246A1 (it) 2003-12-09
DE60311351T2 (de) 2007-05-24
ATE352310T1 (de) 2007-02-15
EP1369121B1 (de) 2007-01-24
PT1369121E (pt) 2007-04-30
EP1369121A1 (de) 2003-12-10

Similar Documents

Publication Publication Date Title
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
SE0001899D0 (sv) New compounds
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
NO20003698L (no) Orale sammensetninger
TR200001203T2 (tr) Yeni birleşik maddeler
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
CO4290417A1 (es) Nuevas benzoilguanidinas como medicamentos y su preparacion .
EA200400664A1 (ru) Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii
EP2767291A3 (de) Behandlung der Glykogenspeicherkrankheit Typ II
ATE335748T1 (de) Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen
HUP0400589A2 (hu) Kolosztrumalapú készítmény
TW200514772A (en) Novel tetrahydropyridine derivatives
SG165326A1 (en) Compositions and methods to counteract oral malodour
DE60311351D1 (de) Verwendung von Zeoliten zur Herstellung oraler Zubereitungen zur Behandlung von Vergiftung
ATE386525T1 (de) 3-substituierte 6,7- dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
ATE292117T1 (de) Zusammensetzungen zur behandlung von hautkrankheiten
NO20010940L (no) TAN-1057 derivater
ATE313541T1 (de) Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe
Huang et al. Prevention of the epoxy resin-based root canal sealers-induced cyclooxygenase-2 expression and cytotoxicity of human osteoblastic cells by various antioxidants
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition